| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |